Revolution Medicines reports phase 1 data for lung cancer drug
Corroborated by 2 sources from 2 publishers
globalhealth4/19/2026
TL;DR
Apr.
Sources
1
Business Insider Markets News
https://markets.businessinsider.com/news/stocks/revolution-medicines-to-present-updated-phase-1-clinical-data-for-zoldonrasib-in-patients-with-previously-treated-kras-g12d-non-small-cell-lung-cancer-at-the-2026-aacr-annual-meeting-1036035725
4/19/2026
2
Investing.com News
https://www.investing.com/news/company-news/revolution-medicines-reports-phase-1-data-for-lung-cancer-drug-93CH-4622240
4/19/2026